ZymoGenetics, a subsidiary of Novo Nordisk of Denmark, is pursuing an aggressive approach to drug discovery centered on its core expertise: protein discovery and bioinformatics.
The programmatic needs, future growth patterns and corporate culture is reflected in the design of offices, common areas, and flexible space for additional laboratories.
The design for the new facility engages a steeply sloping site, which is across the street from the company’s existing laboratories in Seattle’s landmark Lake Union Steam Plant. The design complements the existing building, with large vertical windows bringing in light and view. The building was created with simple materials of brick, concrete and corrugated metal. Massing was developed to create visual interest and scale along Eastlake Avenue.
The project received an AIA Wisconsin Merit Award in 2000.